Protalix BioTherapeutics Inc (PLX)
1.18
-0.03
(-2.48%)
USD |
NYAM |
Apr 25, 16:00
1.20
+0.02
(+1.69%)
Pre-Market: 20:00
Protalix BioTherapeutics Net Income (TTM): 8.312M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.312M |
| September 30, 2023 | 10.62M |
| June 30, 2023 | 8.901M |
| March 31, 2023 | -15.77M |
| December 31, 2022 | -14.93M |
| September 30, 2022 | -17.85M |
| June 30, 2022 | -18.49M |
| March 31, 2022 | -24.39M |
| December 31, 2021 | -27.58M |
| September 30, 2021 | -20.52M |
| June 30, 2021 | -20.76M |
| March 31, 2021 | -13.66M |
| December 31, 2020 | -6.523M |
| September 30, 2020 | -6.629M |
| June 30, 2020 | -5.752M |
| March 31, 2020 | -9.345M |
| December 31, 2019 | -18.28M |
| September 30, 2019 | -24.00M |
| June 30, 2019 | -25.76M |
| March 31, 2019 | -26.48M |
| December 31, 2018 | -26.46M |
| September 30, 2018 | -34.33M |
| June 30, 2018 | -40.44M |
| March 31, 2018 | -31.53M |
| December 31, 2017 | -83.44M |
| Date | Value |
|---|---|
| September 30, 2017 | -72.76M |
| June 30, 2017 | -68.61M |
| March 31, 2017 | -79.92M |
| December 31, 2016 | -29.36M |
| September 30, 2016 | 46.16M |
| June 30, 2016 | 49.63M |
| March 31, 2016 | 55.41M |
| December 31, 2015 | 58.04M |
| September 30, 2015 | -23.33M |
| June 30, 2015 | -27.52M |
| March 31, 2015 | -28.57M |
| December 31, 2014 | -29.94M |
| September 30, 2014 | -32.36M |
| June 30, 2014 | -30.10M |
| March 31, 2014 | -30.81M |
| December 31, 2013 | -27.79M |
| September 30, 2013 | -26.78M |
| June 30, 2013 | -26.51M |
| March 31, 2013 | -10.04M |
| December 31, 2012 | -11.62M |
| September 30, 2012 | -10.65M |
| June 30, 2012 | -14.05M |
| March 31, 2012 | -37.38M |
| December 31, 2011 | -36.53M |
| September 30, 2011 | -36.14M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-27.58M
Minimum
Dec 2021
10.62M
Maximum
Sep 2023
-12.76M
Average
-15.77M
Median
Mar 2023
Net Income (TTM) Benchmarks
| Agenus Inc | -245.76M |
| InfuSystems Holdings Inc | 0.872M |
| Corbus Pharmaceuticals Holdings Inc | -44.60M |
| AIM ImmunoTech Inc | -28.96M |
| Armata Pharmaceuticals Inc | -69.04M |